Huginai vs TradingView: Which AI Trading Tool Is Right for You?
TradingView, if you need a tool today. TradingView is a finished product you can buy. Huginai is a paper-only research project with no signup, no paid plan and nothing to buy. Here is the breakdown anyway, because what we tested and closed is worth reading.
| Feature | Huginai | TradingView |
|---|---|---|
| Can you buy it | No. No signup, no checkout, no paid plansDemo dashboard at /app, sample data only | Yes — free tier plus paid plansCurrent prices on tradingview.com |
| AI signal generation | Built, then closed40% measured win rate vs the 57.4% needed to break even | Screeners and alertsPrice and volume based |
| Social media collectors | Twitter/X and Telegram readers in the repoResearch stack, not a service you get | Not available |
| On-chain data | DexScreener, Etherscan, Hyperliquid readersPublic endpoints, no user access | Not available |
| Telegram alerts | Internal operator bot only — no user alerts | Price alerts |
| Paper trading | Automated and paper only, by standing rule | Manual paper trading |
| Signal audit chain | Recorded internally, not published | Not available |
| Published results | Failures includedDirectional book autopsy, plus a 60-day funding-carry paper forward test | Not applicable |
| Charting tools | None | Industry leading |
| Custom indicators | Not available | Pine Script |
| Community ideas | Not available | Millions of shared ideas |
| Live execution | None — paper and testnet only, real capital is never deployed | Broker integrations |
| Best for | Reading how a signal book was tested and killed | Technical analysis traders |
Where TradingView wins
TradingView has spent over a decade building the best charting platform in the world. If your trading is primarily technical analysis based — moving averages, RSI, support and resistance, custom Pine Script indicators — TradingView is unmatched.
- Chart quality: The cleanest, most customizable charting interface available, with 100+ built-in indicators and the ability to write your own in Pine Script.
- Community: Millions of published chart ideas from traders worldwide. Excellent for finding new setups and perspectives.
- Coverage: Stocks, forex, crypto, futures, and indices on a single platform.
- Price: A paid plan costs less than most data subscriptions. Current pricing is on tradingview.com.
The key limitation: TradingView’s intelligence is entirely price and volume based. It cannot tell you why a move is happening, only that price is doing something notable relative to historical patterns.
What Huginai actually is
A research stack, run by one operator, that reads public data and trades on paper. It is not sold, and it is not a substitute for TradingView. Here is what exists and what was measured.
- Collectors that run: Twitter/X, Telegram, RSS news, TradingView ideas, DexScreener, Etherscan and Hyperliquid readers, feeding a Postgres store. All public endpoints.
- The directional signal book is closed. Three cohorts, zero of them profitable. The final scenario returned −2.31% NAV. Measured win rate 40%, against the 57.4% needed to break even given the payoff shape. No positive slice at n≥5 on any axis — side, conviction bucket, source, ticker, or entry hour. The book is not being tuned or restarted.
- Conviction scoring was anti-predictive in all three cohorts. The 1–10 score that fronted the old product is excluded from gating and sizing.
- One thing survived measurement: a Hyperliquid funding-carry basket — short the perp against spot on coins where the funding floor holds. Over 60 days, net of taker fees and 5bps of assumed slippage per leg per side: HYPE 5.6% APR with 96.7% positive days, NEAR 5.2% with 100%, LDO 3.9% with 96.7% — and LDO at 3.9% sits below the 4.5% the desk requires before considering capital. It runs as a paper forward-test with a kill rule (auto-close when the trailing 7-day funding sum drops below 7 bps).
- Paper only, always. No real capital is deployed. There is no live executor, and none is being sold.
That is the whole inventory. Everything else — accounts, alerts for users, an API, a public trade log — does not exist today.
The carry figures close a 60-day window that ended 2026-07-08 and were re-costed on 2026-08-13, so they are already old. They read 6.4–7.7% before slippage entered the cost model; that earlier version was an upper bound.
The honest verdict
If you need a tool this week, use TradingView. Huginai has nothing to sell you and nothing to plug in. What it has is a written record of what was tested and what died:
- A multi-source directional signal engine, measured over three cohorts and shut down at a 40% win rate
- A Binance funding-arbitrage line, closed as structurally unworkable
- One carry construction still under paper forward-test, with its fees, kill rule and daily sign flips written down
Most tools in this category publish their wins. This one publishes the autopsy. Read it, take the method, and run your own numbers.
Questions
No. TradingView is a finished charting product you can buy and use today. Huginai is a paper-only research project: no signup, no paid plan, no live service. This comparison is useful for deciding what to read, not what to buy.
There is nothing to plug in. Huginai runs no public service — no accounts, no user alerts, no API. The only public surface is the demo dashboard at /app, which renders sample data behind a permanent DEMO banner.
TradingView offers community scripts, screeners and alerts built on price and volume. Huginai built a multi-source directional signal engine and then closed it: three cohorts, a measured 40% win rate against the 57.4% needed to break even, and a conviction score that was anti-predictive in all three.
Huginai is not for sale. There are no plans, no checkout and no billing — the demo dashboard is open and that is the whole of it. TradingView publishes its own pricing on tradingview.com.
What you can actually do today
Open the demo dashboard. It renders synthetic sample data behind a permanent DEMO banner — no account, no live feed, nothing to pay for. There is no other access path right now.
Already using TradingView? Keep it. Nothing here replaces charting.